Search

Suresh Hiran Silva

from Cary, NC
Age ~45
Get Report
Related to:
Timothy Nihal Desaram, 79Yasushi Desaram, 51Sampath D Silva, 53Chandima D Silva, 56Swarna Latha Silva, 88Anu Sahabandu, 45Dinithi K Senadheera, 63Ayanthi U Silva, 52Ayomi N Silva, 51
Connected to:
Abelardo G Silva, 52Abilio N Silva, 65Abimael B Silva, 61Adalton A Silva, 48Adan Silva, 69Admilson H Silva, 61Aeschylus A Silva, 56Ageu O Silva, 59Agostinho Silva, 55Aholibama M Silva, 70

Suresh Silva Phones & Addresses

  • Cary, NC

Publications

Us Patents

Compositions And Methods For Adjoining Type I And Type Ii Extracellular Domains As Heterologous Chimeric Proteins

View page
US Patent:
20200261537, Aug 20, 2020
Filed:
Apr 8, 2020
Appl. No.:
16/843029
Inventors:
- Durham NC, US
George FROMM - Durham NC, US
Suresh DE SILVA - Durham NC, US
Neal Schilling - Durham NC, US
International Classification:
A61K 38/17
C07K 14/00
C07K 19/00
Abstract:
The present invention relates to, inter alia, compositions and methods, including chimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity. In part, the invention provides, in various embodiments, fusions of extracellular domains of transmembrane proteins that can have stimulatory or inhibitory effects.

Compositions And Methods For Adjoining Type I And Type Ii Extracellular Domains As Heterologous Chimeric Proteins

View page
US Patent:
20200246431, Aug 6, 2020
Filed:
Mar 9, 2020
Appl. No.:
16/813165
Inventors:
- Durham NC, US
George FROMM - Durham NC, US
Suresh DE SILVA - Durham NC, US
Neal Schilling - Durham NC, US
International Classification:
A61K 38/17
C07K 19/00
C07K 14/00
Abstract:
The present invention relates to, inter alia, compositions and methods, including chimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity. In part, the invention provides, in various embodiments, fusions of extracellular domains of transmembrane proteins that can have stimulatory or inhibitory effects.

Compositions And Methods For Adjoining Type I And Type Ii Extracellular Domains As Heterologous Chimeric Proteins

View page
US Patent:
20200101136, Apr 2, 2020
Filed:
Nov 8, 2019
Appl. No.:
16/678382
Inventors:
- Durham NC, US
George FROMM - Durham NC, US
Suresh DE SILVA - Durham NC, US
Neal SCHILLING - Durham NC, US
International Classification:
A61K 38/17
C07K 14/00
C07K 19/00
Abstract:
The present invention relates to, inter alia, compositions and methods, including chimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity. In part, the invention provides, in various embodiments, fusions of extracellular domains of transmembrane proteins that can have stimulatory or inhibitory effects.

Compositions And Methods For Adjoining Type I And Type Ii Extracellular Domains As Heterologous Chimeric Proteins

View page
US Patent:
20190151413, May 23, 2019
Filed:
Nov 28, 2018
Appl. No.:
16/203469
Inventors:
- Durham NC, US
George Fromm - Durham NC, US
Suresh De Silva - Durham NC, US
International Classification:
A61K 38/17
C07K 14/00
C07K 19/00
Abstract:
The present invention relates to, inter alia, compositions and methods, including chimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity. In part, the invention provides, in various embodiments, fusions of extracellular domains of transmembrane proteins that can have stimulatory or inhibitory effects.

Compositions And Methods For Adjoining Type I And Type Ii Extracellular Domains As Heterologous Chimeric Proteins

View page
US Patent:
20180326004, Nov 15, 2018
Filed:
Jun 29, 2018
Appl. No.:
16/024209
Inventors:
- Durham NC, US
George FROMM - Durham NC, US
Suresh DE SILVA - Durham NC, US
Neal SCHILLING - Durham NC, US
International Classification:
A61K 38/17
C07K 14/00
C07K 19/00
A61K 38/00
Abstract:
The present invention relates to, inter alia, compositions and methods, including chimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity. In part, the invention provides, in various embodiments, fusions of extracellular domains of transmembrane proteins that can have stimulatory or inhibitory effects.

Compositions And Methods For Adjoining Type I And Type Ii Extracellular Domains As Heterologous Chimeric Proteins

View page
US Patent:
20180326005, Nov 15, 2018
Filed:
Jun 29, 2018
Appl. No.:
16/024214
Inventors:
- Durham NC, US
George Fromm - Durham NC, US
Suresh De Silva - Durham NC, US
Neal Schilling - Durham NC, US
International Classification:
A61K 38/17
C07K 14/00
C07K 19/00
A61K 38/00
Abstract:
The present invention relates to, inter alia, compositions and methods, including chimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity. In part, the invention provides, in various embodiments, fusions of extracellular domains of transmembrane proteins that can have stimulatory or inhibitory effects.

Compositions And Methods For Adjoining Type I And Type Ii Extracellular Domains As Heterologous Chimeric Proteins

View page
US Patent:
20180326006, Nov 15, 2018
Filed:
Jun 29, 2018
Appl. No.:
16/024218
Inventors:
- Durham NC, US
George FROMM - Durham NC, US
Suresh DE SILVA - Durham NC, US
Neal SCHILLING - Durham NC, US
International Classification:
A61K 38/17
C07K 14/00
C07K 19/00
A61K 38/00
Abstract:
The present invention relates to, inter alia, compositions and methods, including chimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity. In part, the invention provides, in various embodiments, fusions of extracellular domains of transmembrane proteins that can have stimulatory or inhibitory effects.

Compositions And Methods For Adjoining Type I And Type Ii Extracellular Domains As Heterologous Chimeric Proteins

View page
US Patent:
20180326007, Nov 15, 2018
Filed:
Jun 29, 2018
Appl. No.:
16/024226
Inventors:
- Durham NC, US
George Fromm - Durham NC, US
Suresh De Silva - Durham NC, US
Neal Schilling - Durham NC, US
International Classification:
A61K 38/17
C07K 14/00
C07K 19/00
A61K 38/00
Abstract:
The present invention relates to, inter alia, compositions and methods, including chimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity. In part, the invention provides, in various embodiments, fusions of extracellular domains of transmembrane proteins that can have stimulatory or inhibitory effects.
Control profile
Suresh Hiran Silva from Cary, NC, age ~45 Get Report